Schedule 13D ownership disclosure

Silence Therapeutics plc

Security class unavailable · CUSIP: G8128Y157

Event date: 2024-03-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
16.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-24-078938
Form type
SC 13D/A
Filer
Griffiths Richard Ian
CIK
CIK 1846370
Filed
Mar 27, 2024
Reporting period
Mar 27, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub